• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.52%

    Alcobra Ltd. (ADHD)

    -NasdaqGM
    5.61 Down 0.16(2.77%) Apr 17, 4:00PM EDT
    Add to Portfolio
    Prev Close:5.77
    Open:5.70
    Bid:N/A
    Ask:8.50 x 300
    1y Target Est:21.00
    Beta:1.935
    Next Earnings Date: 6-May-15ADHD Earnings announcement
    Day's Range:5.51 - 5.83
    52wk Range:3.12 - 22.19
    Volume:145,465
    Avg Vol (3m):248,924
    Market Cap:76.87M
    P/E (ttm):N/A
    EPS (ttm):-2.40
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ADHDDown 2.77%76.87M
    JNJDown 0.21%276.88B
    NVSDown 0.82%245.76B
    SHPGUp 0.10%47.81B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.28
    Quarterly EPS Est (Mar-15) :-0.29
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alcobra Ltd., a biopharmaceutical company, focuses on the development and commercialization of oral drug candidates. The company is primarily developing MDX (metadoxine), an onset/extended release formulation of the chemical pyridoxine pyroglutama... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback